They observed that fragile-site associated tumor suppressor (FATS), a novel oncogene involved in LC, was significantly downregulated in NSCLC tissues compared with adjacent normal tissues and was associated with the survival of NSCLC patients. Here, C10orf90 is linked to laryngotracheoesophageal cleft.